#GLP1s like #Ozempic come as close to wonder drugs as perhaps we've ever had.
They're also meeting a really weird moment: the wellness and appearance obsessed algorithmic age
@ezraklein and I talked about these two things colliding. Weirdness ensues.
https://t.co/LxUZxWnlIM
NEW:
RFK Jr.'s efforts to revamp America’s food system have hit their biggest hurdle yet: The White House.
Trump aides are concerned Kennedy's ideas aren't feasible and could fuel litigation against food companies.
One of Kennedy’s top aides, Calley Means, accused White House officials of trying to block the definition to cater to special interests.
Inside the clashes over the future of American food:
With @jessenewman13 & @jdawsey1 🎁🔗https://t.co/wAjAQn8Gag
The point here is that eating well is more about our environments than a test of will.
Of course, many of us live in places that make it nearly impossible to eat the right things.
The the ultimate goal is creating healthy food environments for all. More in our book 👇
One of the key messages of #diet culture is that eating well is something you choose to do each day.
But what if the problem isn't your choices but the food environment around you?
That's the idea behind the Food Intelligence Five, principles from @KevinH_PhD and I to eat by:
5) Don't lose sight of the boring nutrition fundamentals.
There's a lot of confusing noise about nutrition right now, especially on social media.
Ignore it, and stick with well-founded basics.
New research in @JAMANetworkOpen suggests that describing discontinuations of obesity medicines as a "compliance problem" is profoundly misleading.
https://t.co/SM6n2nOANS
Why do people with type 2 diabetes often lose less weight with GLP-1–based therapies?
My first paper as an @AstraZeneca employee uses mathematical modeling to suggest that GLP-1 induced glycemic improvements may reduce urinary glucose excretion and energy expenditure, partially offsetting negative energy balance—particularly with background SGLT2 inhibitor therapy.
Preprint: https://t.co/MwcAaeiwt0
For decades, ppl have talked about the toxic food environment and how it’s stacked against most people.
For decades, little’s changed policy-wise.
I increasingly think there’s only one way out.
That way is litigation.
https://t.co/pXtFw01PVG @nytopinion
Americans want to inject unproven chemicals. They may soon get their way.
An FDA advisory meeting voted to make it easier to access six experimental #peptides. But the meeting was never just about peptides.
I wrote about why for @nytopinion
https://t.co/NjI5yyKMLz
Until #GLP1s, there's never been a drug states have so completely lost control over.
I spoke to Apple News In Conversation about what this tells us about our health system, how it needs to change, and more. You can listen here.
https://t.co/ZqRRFOuNDO
GLP-1s are making people healthier.
But they're also a tool for upward mobility, especially for women.
Like it or not (I emphatically don't), we live in a society where a woman's weight can close doors for her.
The drugs just might open them.
https://t.co/BPYDcV6xXp
"If we deny free will when it comes to the worst of our behaviors, the same must also apply to the best." - Robert Sapolsky
HT @juliaoftoronto@KevinH_PhD, Food Intelligence
#obesity#food#science